Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01823276 · ClinicalTrials.gov registry record · NA

Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape (SERE) School

A NA study, sponsored by United States Army Research Institute of Environmental Medicine.

Completed
Registry status
NA
Development phase
73
Enrollment target

NCT01823276: Completed NA study, sponsored by United States Army Research Institute of Environmental Medicine.

NCT01823276 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01823276, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target

Study Summary

The objective of the proposed research is to determine if tyrosine, an amino acid found in protein-containing foods, will mitigate the cognitive deficits and adverse effects on behavior and mood produced by exposure to military stress. This study will be conducted at the Army Survive, Evade, Resist, Escape (SERE) school at Fort Bragg, NC. Tyrosine is the dietary precursor of the catecholamine norepinephrine, a key brain neurotransmitter that is critical for the central nervous system (CNS) response to various types of acute stress. Psychological stress increases catecholamine turnover in the brain, increasing the requirement for tyrosine to support synthesis of norepinephrine. Animal and human studies have shown that tyrosine supplementation can produce beneficial effects on cognitive and physiological functions during exposure to a variety of acute stressors. This project will determine if volunteers treated with supplemental tyrosine during stressful phases of SERE training experience less degradation in cognitive performance and mood than volunteers treated with placebo. Tyrosine or placebo will be administered in a specially developed food bar provided to volunteers. The bar is part of a prototype of ration-component designed for use during assault operations. A between-subjects, double blind experimental design will be employed. Tyrosine, an amino acid found in most protein-containing foods, has been tested in hundreds of volunteers without adverse effects. Approximately 100 volunteers will be recruited from several SERE classes to ensure up to 82 volunteers complete the study. They will be tested during several portions of SERE. A comprehensive but brief battery of cognitive tests, as well as saliva and blood samples, will be collected in a manner that does not interfere with ongoing training. Hypotheses: 1. The adverse effects of psychological stress on cognitive performance and mood during SERE school will be reduced when volunteers are given supplement

Interventions

  • OTHER Placebo Bar
  • OTHER Tyrosine-Containing Bar

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2013-05
Est. Completion 2013-08
Phase NA

What the finished NCT01823276 record still lists

NCT01823276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo Bar is the first listed.

NCT01823276 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01823276 about?

NCT01823276 is a clinical study titled "Effect of Tyrosine on Behavioral, Physiological and Nutritional Status During Survive, Evade, Resist, Escape (SERE) School". The objective of the proposed research is to determine if tyrosine, an amino acid found in protein-containing foods, will mitigate the cognitive deficits and adverse effects on behavior and mood produced by exposure to military stress. This study will be conducted at the Army Survive, Evade, Resist,...

What is the current status of trial NCT01823276?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2013-05. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01823276?

The interventions under investigation include: Placebo Bar (OTHER), Tyrosine-Containing Bar (OTHER).

Who is sponsoring clinical trial NCT01823276?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01823276's enrollment target sits among peer trials

73 1089th of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03661307 · 73 participants · Phase 1

    Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

  • NCT05386108 · 73 participants · Phase 1

    Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • NCT05961592 · 73 participants · Phase 1

    R-2487 in Patients With Rheumatoid Arthritis

  • NCT06150664 · 73 participants · Phase 1

    A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01823276, the US trial registry maintained by the National Library of Medicine. NCT01823276 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.